COST-EFFECTIVENESS ANALYSIS OF FIRST-LINE TREATMENT WITH CRIZOTINIB IN ROS1-REARRANGED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN CANADA

Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1-rearranged advanced non-small cell lung cancer (NSCLC) in Canada

Abstract Introduction While no direct comparative data exist for crizotinib in ROS1+ non-small cell lung cancer (NSCLC), studies have suggested clinical benefit with this targeted agent.The objective of this study was to assess the cost-effectiveness of crizotinib compared to standard platinum-doublet chemotherapy for first-line treatment of ROS1+

read more


Proposal of quantitative analysis method concerning rotational motion of lower limb joints including joint moments as well as joint angles

In human gait motion analysis, which is one useful method for efficient physical rehabilitation to define various quantitative evaluation indices, joint angles and joint INCENSE COSTEN loads are measured during gait.Recently, it is thought that trans-femoral amputees with the prosthetic limb must regain motion pattern by refined rehabilitation prog

read more